Old flagship sponsor returns to back Proteas for World Test Championship final
The final takes place at Lord's from 11-15 June.
CSA CEO Pholetsi Mosekki says they are humbled to be backed by a brand that reflects 'a shared belief in the power of unity, resilience, and national pride'.
For more Proteas news, visit our dedicated section.
The Proteas will have a familiar ally back in their corner when they tackle Australia in the World Test Championship final at Lord's in London from 11-15 June.
Castle Lager, which was once synonymous with South African cricket, will be the Proteas' official team sponsor for the duration of the showpiece at the 'Home of Cricket'.
READ | To Ngidi or to Paterson? The Lord's slope could hold the answer
The flagship brand of South African Breweries (SAB) will feature on the leading sleeve of the Proteas' playing kit.
Cricket SA's CEO, Pholetsi Moseki, welcomed Castle coming on board for the World Test Championship final.
'The show of support for the Proteas Men reaffirms Castle Lager's long-standing and consistent support of South African cricket.
'We are humbled to go into the WTC Final with a brand that reflects a shared belief in the power of unity, resilience, and national pride.
'Castle Lager's backing serves as a rallying cry to the nation to stand behind our boys as they chase Test cricket greatness on the global stage,' Moseki said.
Castle's Brand Director, Thomas Lawrence, added: 'Castle Lager is proud to be back on the Proteas Test jersey - a symbol of resilience, pride, and South African excellence.
'Our return marks not just a sponsorship, but a renewed commitment to the spirit of Test cricket and the values it shares with our brand: heritage, endurance, and unity. Together with the Proteas, we look forward to writing the next great chapter in South African cricket.'
The South African squad will assemble in Arundel, England on 31 May and will play a warm-up match against Zimbabwe from 3-6 June, before heading to London on 7 June.
🗞Announcement 🗞
Castle Lager will be the official team sponsor to the Proteas Men for the duration of ICC World Test Championships (WTC) Final taking place from 11 – 15 June at Lord's Cricket Ground in London.
@CastleLagerSA, the flagship brand of South African Breweries… pic.twitter.com/2cN8pmmPlp
— Proteas Men (@ProteasMenCSA) May 20, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
2025 Accommodation Barometer: UK Sector Resilient, Yet Pressed on Talent and Digital Fronts
AMSTERDAM, July 30, 2025 /PRNewswire/ -- A new set of reports from Statista, produced in partnership with sheds light on key developments shaping Europe's accommodation sector — from evolving skills requirements and investment patterns to diverging national outlooks and the uneven pace of digital transformation. UK hoteliers report a stable and optimistic outlook for 2025, with just over half experiencing positive economic development in recent months. Only 4% feel pessimistic about the upcoming six months. UK accommodations' hiring appetite is low compared to neighbours in Europe, with salary expectations seen as a key recruitment challenge. While AI's potential is recognised, barriers like costs and integration difficulties persist. As tourism-related levy proposals crop up across the UK, most accommodations anticipate little impact on occupancy, but one in five expect a negative effect. Chain accommodation providers tend to report greater optimism and investment intent than independent businesses. "This year's data from the UK points to two pressing challenges: a widening skills gap and uneven digital progress," said Thomas Hinton, Data Journalist at Statista. "Nearly half of respondents cite difficulties hiring qualified staff. Meanwhile, while AI is making inroads in some areas, broader adoption remains limited — often due to cost or technical hurdles." About the Barometer: The European Accommodation Barometer 2025 — in its fifth edition — draws on survey responses from more than 1,000 hoteliers across the continent. It combines a comprehensive Europe-wide report in English with 14 country-specific editions, available in local languages, for Austria, Croatia, France, Germany, Greece, Ireland, Italy, the Netherlands, Nordics, Poland, Portugal, Spain, Switzerland, and the UK. All reports are available for free download from the Statista website. Click here to view picture. Shanhong Liu Senior Editorial Researcher & Project Manager Phone: +49 40 284 841 791 View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 minutes ago
- Yahoo
Kaion Lisbie aiming to be quick out of the blocks for Colchester United
KAION Lisbie says he is looking forward to linking up with his older brother Kyreece after joining Colchester United. The talented young winger, who is the son of former Colchester favourite Kevin Lisbie, has teamed up with the U's under-21 squad for this season, after signing his first professional deal. Lisbie told "As soon as Colchester put an offer on the table, I was really excited. LISTEN: Elliott Ward on U's U21s' pre-season draw at Braintree "I wanted to get going as soon as possible and knowing the history of my Dad playing here, I just wanted to get going and do as much as I can to live up to the standards we have here. "I've never played with Kyreece before but it's really good to play with him and I want to get started. "We're both fast - he says he's faster than me and I say I'm faster than him, so it's good competition between us! "We're very similar in that we love balls in behind and getting on the end of them and 1v1s with defenders. (Image: "Signing my pro contract is something I've dreamt of for a long time. "Everyone has welcomed me and it feels like family, so I'm excited to get started." Lisbie played for Leyton Orient's academy until under-13 level, when he was released. Colchester under-21s draw at Braintree Town in pre-season clash He spent time after that working with his father Kevin on aspects his game, leading to a two-year spell at West Ham United's foundation. "That was a really big part of my development to be fair, it helped me get my confidence back," added Lisbie. A Colchester XI won 1-0 at Ipswich Town in a behind-closed-doors pre-season game, on Tuesday afternoon. Arthur Read scored the U's winner from the penalty spot, after Samson Tovide won the spot-kick. Three trialists featured for Danny Cowley's side in the match along with the likes of Kane Vincent-Young, Owura Edwards and John-Kymani Gordon.
Yahoo
14 minutes ago
- Yahoo
AstraZeneca Just Missed Estimates, but Here's Why Bulls Aren't Worried Yet
Parnassus Investments, an investment management firm, released its 'Parnassus Value Equity Fund' second-quarter 2025 investor letter. The fund focuses on owning a concentrated portfolio of U.S. large-cap stocks. The full letter is available for download here. For the second quarter of 2025, the fund reported a net return of 7.24%, outperforming its benchmark, the Russell 1000 Value Index, which returned 3.79% for the same period. The fund's top 5 holdings are also listed in the letter, showing the firm's main investment positions heading into 2025. One of the companies mentioned in the letter is AstraZeneca PLC (NASDAQ:AZN). AstraZeneca PLC (NASDAQ:AZN), a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Over the past month, AstraZeneca PLC (NASDAQ:AZN) rose 4.01%, and appreciated 12.91% over the last 12 months. On July 29, 2025, AstraZeneca PLC (NASDAQ: AZN) shares closed at $73.98, with a market capitalization of $229.372 billion. Here is what they have to say about AstraZeneca PLC (NASDAQ:AZN) in their investor letter: "AstraZeneca PLC (NASDAQ:AZN), an Anglo-Swedish drugmaker, missed firstquarter revenue estimates as sales of key oncology drugs missed forecasts. But the company maintained its 2025 profit outlook, calling the impact of U.S. tariffs manageable." AstraZeneca Just Missed Estimates, but Here's Why Bulls Aren't Worried Yet AstraZeneca PLC (NASDAQ:AZN) is not included in our list of the 30 most popular stocks among hedge funds. According to our data, 56 hedge fund portfolios held positions in AstraZeneca PLC (NASDAQ:AZN) at the end of the first quarter of 2025, up from 55 in the previous quarter. AstraZeneca PLC (NASDAQ:AZN) exceeded earnings expectations in Q1 2025, EPS of $1.30 versus the $1.10 consensus estimate. While we acknowledge the potential of AZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. AstraZeneca PLC (NASDAQ:AZN) is not included in our list of the 30 most popular stocks among hedge funds. According to our data, 56 hedge fund portfolios held positions in AstraZeneca PLC (NASDAQ:AZN) at the end of the first quarter of 2025, up from 55 in the previous quarter. AstraZeneca PLC (NASDAQ:AZN) exceeded earnings expectations in Q1 2025, EPS of $1.30 versus the $1.10 consensus estimate. While we acknowledge the risk and potential of AZN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AZN and that has 10,000% upside potential, check out our report about this cheapest AI stock. In another article, we covered AstraZeneca PLC (NASDAQ:AZN) and Goldman Sachs' views on the company in the previous quarter. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
